PIA
ELGX

Piedmont Investment Advisors’s Endologix Inc ELGX Stock Holding History

Piedmont Investment Advisors’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-144
Closed -$8K – 2853
2018
Q2 		$8K Buy
+144
New +$7.3K ﹤0.01% 1952

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return

Piedmont Investment Advisors's ELGX Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Endologix Inc (ELGX) in Q3 2018, closing a stake of 144 shares — an estimated $8K sold.

Piedmont Investment Advisors first reported a position in ELGX in Q2 2018 and held it in 1 quarter. The position peaked at $8K in Q2 2018. 100 funds tracked by Wall St. Rank hold ELGX as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Endologix Inc position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 144 Endologix Inc shares in Q3 2018, an estimated $8K.
  • Piedmont Investment Advisors first reported a position in Endologix Inc in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Endologix Inc position peaked at $8K in Q2 2018.
  • 100 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.